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Abstract 
Objective: In our routine review of Oral Submucous Fibrosis (OSMF) biopsies, we observed decreased adipose tis-
sue even though most are from buccal mucosa. Pathogenesis of OSMF has demonstrated the role of Transforming 
Growth Factor β (TGF β), in causing fibrosis. This study aims to correlate the role of TGF β with loss of adipose 
tissue in OSMF. 
Study Design: From our archives, 84 OSMF cases (24 early and 60 advanced OSMF) were screened for adipose 
tissue. Immunoexpression of TGF β in these cases were investigated. 
Results: Adipose tissue was seen in 67% of early OSMF and in 13% of advanced cases. Early cases showed more 
intense TGF β staining of epithelium, fibroblast, macrophages and inflammatory cells than the advanced cases. 
Conclusion: These findings suggest that TGF β plays a key role in causing lipodystrophy in OSMF and is secreted 
more during early course of the disease than in advanced stage. 
Key words:  Adipose tissue, oral submucous fibrosis (OSMF), transforming growth factor β (TGF β), lipodystrophy.
Kale AD, Mane DR, Shukla D. Expression of transforming growth factor 
β and its correlation with lipodystrophy in oral submucous fibrosis: An 
immunohistochemical study. Med Oral Patol Oral Cir Bucal. 2013 Jan 
1;18 (1):e12-8.   
 http://www.medicinaoral.com/medoralfree01/v18i1/medoralv18i1p12.pdf
Article Number: 18226         http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
doi:10.4317/medoral.18226
http://dx.doi.org/doi:10.4317/medoral.18226
Introduction
Oral Submucous Fibrosis (OSMF) is a high risk precan-
cerous condition, predominantly affecting south East 
Asians. Studies have shown that none of the treatment 
approaches is completely effective in these patients and 
relapse is a common complication (1,2). Histologically, 
Pindborg and Sirsat described four consecutive stages 
depending upon hyalinization, fibroblastic response and 
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inflammation (3). Further, Binnie and Cawson revealed 
degeneration of muscle fibers together with collagen-
ous subepithelial zone (4). Pathogenesis of OSMF has 
explained the role of growth factors and cytokines that 
are secreted by inflammatory cells during the disease 
process which promotes fibrosis by inducing prolifera-
tion of fibroblasts, upregulating collagen synthesis and 
down regulating collagenase production (5). One such 
key molecule is Transforming Growth Factor β (TGF β) 
that is a central matrix modulator. 
TGF β has been found to play role in regulation of 
cell growth, differentiation, proliferation, migration, 
adhesion and apoptosis (6). It causes increased pro-
liferation of fibroblasts (7) but inhibits proliferation 
of epithelial cells; causes differentiation of neuronal 
cells, but blocks differentiation of mesenchymal cells 
(8). TGF β isoforms exhibit overlapping but  distinct 
temporal and spatial patterns of expression in vivo. 
TGF β1 is expressed in epithelial, hematopoietic, and 
connective tissue cells, TGF β2 in epithelial and neu-
ronal cells and TGF β3 primarily in mesenchymal 
cells (9).
In OSMF, TGF β is a key mediator of tissue fibrosis 
resulting from accumulation of extra cellular matrix 
(ECM). Its activator protein induces transcription of 
COL1A1 procollagen gene (9–11), increases levels and 
activities of the N–and C–procollagen proteinases (12) 
and promotes the expression of lysyl oxidase (LOX), an 
essential enzyme for final processing of collagen fibers 
into a stabilized covalently cross–linked mature fibrillar 
form that is resistant to proteolysis (13,14). TGF β also 
decreases the collagen degradation by activating tissue 
inhibitor of matrix metalloproteinase gene (TIMPs) and 
plasminogen activator inhibitor (PAI) gene (12). Al-
though transient TGF β1 activity participates in repair 
and regeneration of tissues, persistent TGF β 1 func-
tion effects excessive fibrosis (11). TGF β causes induc-
tion of connective tissue growth factor (CTGF), which 
further mediates stimulatory actions of TGF β on ECM 
synthesis (15). It also initiates fibrosis in skeletal muscle 
and induces myogenic cells to differentiate into myofi-
broblastic cells in injured muscle (16).
TGF β1 has been implicated in lipodystrophy as dem-
onstrated by Clouthier DE et al (17). Nevertheless there 
is a paucity of information related to adipose tissue in 
OSMF. Over a period of years of our histopathologi-
cal observation of OSMF cases, significant absence 
of adipose tissue was noted. Could the destruction of 
adipose tissue by TGF β be responsible for the clinical, 
facial and oral appearance of OSMF? This study aims 
to establish if there is any association of degeneration of 
adipose tissue and TGF β. This information would po-
tentially be useful in identifying those OSMF cases in 
which replacement of adipose tissue or supplementing 
anti TGF β drugs could lead to better prognosis.
Material and Methods
-Case Selection
Eighty four formalin-fixed paraffin embedded tissue 
blocks of histopathologically cases of OSMF were re-
trieved from the archives of the Department of Oral and 
Maxillofacial Pathology, KLE VK Institute of Dental Sci-
ences, Belgaum for this study. Institutional Review Board 
and Ethical Committee approval was obtained prior to the 
start of the study. The KLE VK Institute of Dental Scien-
ces actively maintains case histories of all the patients for 
clinical findings. Case histories were evaluated for clinical 
findings like burning sensation, ulceration, trismus, pale 
buccal mucosa firmly attached to underlying tissues, bands 
of palpable fibrosis and sunken cheek appearance. Haema-
toxylin and Eosin (H & E) sections of these OSMF cases 
were reviewed by three oral pathologists and categorized 
into very early, early, moderately advanced and advanced 
OSMF based on classification of Pindborg and Sirsat (3). 
The very early stage OSMF is characterized by finely fi-
brillar collagen, plump young fibroblasts, inflammatory 
cells and dilated blood vessels. The early stage shows early 
juxtaepithelial hyalinization with separate collagen bun-
dles. In moderately advanced stage collagen is moderately 
hyalinized with thickened collagen bundles still separated 
by slight residual edema. In the advanced stage, collagen 
undergoes complete hyalinization with no distinct bun-
dles, absence of fibroblasts.and obliterated blood vessels. 
For ease of evaluation we have classified the cases into two 
groups (a) ‘early’ (24 cases) including very early OSMF 
and early OSMF and (b) ‘advanced’ (60 cases) including 
moderately advanced OSMF and advanced OSMF. Immu-
nohistochemical staining with TGF β was done for these 
OSMF cases. Desmoplastic ameloblastoma, fibroma and 
chronic inflammatory hyperplasia were included in the 
study to assess TGF β expression in inflammatory and fi-
brosed tissues. 
-Immunohistochemistry Protocol
Formalin fixed, paraffin embedded serial tissue sections 
cut at 5 µm were deparaffinized and subjected to im-
munohistochemical technique using Super SensitiveTM 
polymer-HRP Detection System (BIOGENEX Corpo-
rations, San Ramon, CA 94583, USA). Heat induced 
epitope retrieval was done in EZ Antigen retrieval sys-
tem (Biogenex) following 3 cycles of 96ºC for 6 min 
each placing slides in sodium citrate buffer (pH 6.0) 
and finally allowing it to cool at room temperature 
for 20 min. Endogenous peroxidase was blocked with 
3% hydrogen peroxide in water for 15 min. The sec-
tions were then incubated with protein blocking reagent 
for 20 min at room temperature to block the non–specific 
binding sites. The sections were then incubated with a pri-
mary antibody against TGF β (Anti TGF β1, β2, β3, 1D11 
from R&D Systems, 1:200 dilutions) at 4ºC for overnight 
in a humidifying chamber. Following this, all sections 
were washed with PBS again (three times, 10 min each) 
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and then incubated with secondary antibodies that were 
conjugated with poly-horseradish peroxidase reagent for 
a further 20 min. Bound peroxidase was visualized by a 
3,3’diaminobenzidine hydrochloride and counter stain was 
developed with Harris hematoxylin.  Phosphate buffered 
saline of pH 7.6 was used throughout for washing and rins-
ing the slides. To determine the specificity of the antibod-
ies, phosphate–buffered saline was used instead of prima-
ry antibody and secondary antibody was omitted on some 
slides. The intensity of staining of the epithelium (basal 
and superficial) and stroma was assessed as: – negative (no 
staining); + mild (positive staining for less than one-third 
of tissue section) ; ++ moderate (positive staining area 
ranged from one-third to two-third of tissue section) and 
+++ intense (positive staining for more than two-third of 
tissue section). Three independent oral pathologists evalu-
ated the slides and all observers were blinded.
-Data Analysis
Data were entered and analyzed using SPSS 10.0.5 soft-
ware. The Chi–square test and Fisher’s test was used to 
analyze the differences in between the intensity levels 
and percentage positivity in early OSMF and advanced 
OSMF for TGF β positivity and to compare both the 
groups with respect to the presence of adipose tissue. 
Differences with a probability value of <0.05 were con-
sidered statistically significant.
Results
-Clinical Presentation
In the present study, early OSMF cases (24 cases) were 
included which clinically presented with burning sensa-
tion, ulceration, widespread bands of palpable fibrosis and 
histopathologically showed finely fibrillar collagen or in 
separate thick bundles with fibroblasts, inflammatory cells 
and dilated and congested blood vessels. Advanced cases 
(60 cases) in this study presented with trismus, pale buc-
cal mucosa firmly attached to underlying tissues giving a 
tough leathery feeling, vertical fibrous bands palpable at 
soft palate, pterygomandibular raphe, faucial pillars and 
sunken cheek appearance. All the patients had habit of 
areca nut chewing for more than 5 years.
-Haematoxylin and Eosin staining
In H&E sections, all cases demonstrated thickened or com-
pletely hyalinized collagen bundles with atrophic epithe-
lium, decreased cellularity (fibroblasts), compressed blood 
vessels and degeneration of muscle fibres. Amongst the 
early and advanced OSMF only 24 cases out of 84 showed 
presence of adipose tissue. In early OSMF cases, 33% (8 
out of 24 cases) showed no adipose tissue while advanced 
cases 86.7% (52 out of 60 cases) showed lack of adipose tis-
sue. These findings were found to be statistically significant 
with Chi-square analysis with p value being <0.01 (Table 1, 
Fig. 1).
Type of 
OSMF 
No. of 
Cases 
Adipose tissue Chi-square 
analysis Present Absent 
Early 24 16 (66.7%) 8 (33.3%) 
p <0.01 Advanced 60 8 (13.3%) 52 (86.7%) 
Total 84 24 (28.6%) 60 (71.4%) 
Table 1. Distribution of adipose tissue in Early and Advanced OSMF (H&E). 
Data were entered and analyzed using SPSS 10.0.5 software. The Chi–square 
test and Fisher’s test was used to compare both the groups with respect to the 
presence of adipose tissue. These findings were found to be statistically sig-
nificant with p value being <0.01.
Fig. 1. H&E Photomicrograph of a) early OSMF (original magnification 10x) and b) advanced OSMF (original 
magnification 40x) with absence of adipose tissue.
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-Immunohistochemical staining for TGF β
Desmoplastic ameloblastoma, fibroma and chronic in-
flammatory hyperplasia  that served as positive controls 
showed strong TGF β positivity in all the cases (Fig. 
2). These controls verified that the antigenic expression 
was properly preserved in the study group. 
Fig. 2. Photomicrographs showing positive intense type of immuno-
histochemical staining for TGF β (+ + +) in desmoplastic ameloblas-
toma a,b), moderate type of staining (+ + ) in chronic inflammatory 
hyperplasia c,d) and moderate to mild type of staining (+) in fibroma 
e,f) which are taken as positive control (a,c,e- original magnification 
10x; b,d,f- original magnification 40x). 
In TGF β stained sections, out of 24 cases of early OSMF (Fig. 
3), 22 cases (92%) showed mild to intense type of staining in-
tensity for TGF β while only two cases showed no staining. 
Out of 60 advanced cases of OSMF, 34 cases (57%) showed 
mild to moderate TGF β expression, where as 26 cases (43%) 
had no staining for TGF β (Table 2, Fig. 3).
Expression of TGF β was evaluated in the epithelium, 
stromal cells and in the stromal tissue of OSMF. Out 
of the 56 OSMF cases positive for TGF β expression, 
18 cases (32%) showed TGF β expression in superficial 
layers of epithelium where as 31 cases (55%) showed 
expression in basal layers and 7 cases (13%) showed ex-
pression in both superficial and basal layers (Table 3). 
Of the 56 cases of TGF β positive expression, 49 cases 
showed positivity for fibroblast, inflammatory cells and 
endothelial cells and 28 cases demonstrated mild to 
moderate expression in deeper stroma (Table 4, Fig. 3). 
There was no statistical significant difference in rela-
tion to TGF β expression in early and advanced OSMF 
or in its expression in superficial and basal layer of epi-
thelium, stromal cells and also in deeper stroma. 
Discussion
OSMF is an oral disease first described three decades 
ago by Pindborg and Sirsat who graded it histologically 
into four stages depending upon hyalinization, fibro-
blastic response and inflammation (3). OSMF has been 
regarded as a collagen–metabolic disorder. Increased 
collagen production and decreased collagen degrada-
tion results in increased collagen deposition in the oral 
tissue, leading to fibrosis. This is further aggravated by 
the auto-regulatory process of TGF β, which is the main 
trigger for both the increased collagen production and 
decreased degradation pathways and recently has also 
Fig. 3. Immunohistochemistry for TGF β expression in early OSMF 
a,b) and advanced OSMF c,d). Photomicrographs are showing intense 
type of staining for TGF β in early OSMF while only mild TGF β 
expression in advanced OSMF cases. Immunohistochemistry for TGF 
β expression in epithelium and stroma e,f) and  stromal cells g,h) of 
OSMF. Photomicrographs are showing intense staining of basal and 
superficial epithelium in early OSMF where as mild to moderate stain-
ing in advanced OSMF cases. Fibroblast, inflammatory cells and en-
dothelial cells are also showing positive staining (a,e,g- original mag-
nification 10x; b,c,d,f,h- original magnification 40x).
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been found to be responsible in inhibiting adipogenesis. 
Understanding of the molecular events helps in better 
therapeutic intervention of the disease. Thorough li-
terature search through Pubmed and Medline could not 
reveal any data regarding absence of adipose tissue in 
OSMF. Thus, this study aimed to correlate the absence 
of fatty tissue observed in OSMF patients with the un-
derlying molecular events by targeting TGF β.
In the present study epithelium showed more positivity 
in basal layer than superficial layer.  Further the inten-
sity and frequency of staining was more in early OSMF 
than advanced OSMF cases (Table 2,3). Previous stud-
ies have found that external stimuli such as areca nut 
components may induce the development of OSMF by 
activating and stimulating the keratinocytes to secrete a 
series of cytokines, including endothelin (ET)  and TGF 
β 1 (18). Interestingly, Gao Y et al have shown that there 
was  positive expression of TGF β 1 mRNA mainly in 
keratinocytes of early and middle stage OSMF which is 
in agreement with the present study (19). This suggests 
that keratinocytes of OSMF tissue may synthesize and 
release TGF β 1 which may play an important role in the 
pathogenesis of OSMF and participate as a mediator in 
the pathogenetic process of OSMF (19,20). 
Furthermore, stromal cells that are well known secretors 
of TGF β demonstrated better expression in early OSMF 
(88%) as compared to advanced OSMF (47%) though 
stromal staining was equally distributed in both groups 
(Table 4). TGF β positivity was more in early OSMF 
(92%) cases than in advanced OSMF cases (57%) and 
adipose tissue also was seen more in early OSMF cases 
(67%) as compared to advanced cases (13%). Early cases 
showed increased intensity of staining of epithelium, fi-
broblast, macrophages and inflammatory cells than ad-
vanced cases. It was found that in response to external 
stimuli and inflammation, TGF β is secreted more dur-
ing early course of the disease when widespread sheets 
of fibrous bands are palpated. This leads to increased 
fibrous proliferation and destruction of adipose tissue. 
TGF β decreases gradually in advanced cases when the 
patient presents with vertical fibrous bands and sunken 
cheek appearance, as the tissue has already fibrosed and 
lost all its adipose tissue
Previous studies have established that TGF β1 is a regu-
Stage of 
Presentation 
No. of 
cases 
Negative
staining 
Mild
staining 
Moderate 
staining 
Intense 
staining 
Total
positive
staining 
Early  24 2 (8.3%) 4 (16.7%) 12(50%) 6 (25%) 22 (91.7%) 
Advanced  60 26 (43.3%) 20 (33.3%) 14(23.3%) 0 34 (56.7%) 
Total 84 28 (33.3%) 24 (28.6%) 26(31%) 6 (7.1%) 56 (66.7%) 
Table 2. Intensity of TGF β expression in OSMF (IHC).
Stage of 
OSMF 
No. of cases 
with positive 
staining 
No. of cases 
with negative 
staining 
Epithelium
Superficial 
(surface layer) 
        Basal 
(stratum basale) 
Both
superficial 
and basal 
Early 22  2 4 (18.2%) 14 (63.6%)  4(18.2%) 
Advanced 34 26 14 (41.2%)       17 (50%) 3(8.8%) 
Total 56 28 18 (32.1%)  31 (55.4%)    7 (12.5%) 
Table 3. TGF β expression in epithelium of OSMF (IHC).
Fibroblast, inflammatory cells and endothelial Cells 
Stage of 
OSMF 
No. of cases with 
positive staining 
No. of cases with 
negative staining Mild Moderate Intense 
Early  21 3 3(14.3%) 14 (66.7%) 4 (19%) 
Advanced  28 32 17(60.1%) 11 (39.3%) 0 
Total  49 35  20 (40.8%)  25 (51%) 4 (8.1%) 
Stroma 
Early  7 17 3(42.9%) 4 (57.1%) 0 
Advanced   21 39  11 (52.4%) 10 (47.6%) 0 
Total  28 56   14 (50%)   14 (50%) 0 
Table 4. Intensity of TGF β expression in fibroblast, inflammatory cells, endothelial cells and stroma in OSMF 
(IHC).
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lator of adipocyte differentiation and its expression in 
adipose tissue resulted in a lipodystrophy–like syn-
drome (17,21). TGF β1 may inhibit adipogenesis direct-
ly by modulating the expression of critically required 
molecules, or indirectly by enhancing ECM synthesis 
and deposition. It induces pathologic matrix accumu-
lation in the adipose tissue, resulting in severe fibrotic 
disease. It is presumed that the severe fibrosis of the adi-
pose tissue is the underlying cause of the loss of skin 
elasticity, thus creating a tight–skin phenotype (sunken 
cheek appearance) (17). In vitro studies have revealed 
that TGF β1 binds to receptors on the plasma membrane 
of fibroblasts (3T3–L1) and effectively inhibits their 
adipogenic conversion (21). It has been established that 
endogenous TGF β signaling regulates the rate of adi-
pogenesis, and that Smad2 and Smad3 plays key role in 
this endogenous control of differentiation (22). TGF β 
activated Smad proteins interacts with enhancer bind-
ing proteins (C/EBP β or C/EBP δ) and thus inhibits 
adipocyte differentiation (23). Further Petruschke et al, 
found that addition of TGF β at the beginning of the 
differentiation process resulted in a dose–dependent 
reduced expression of glyceraldehyde–3–phosphate de-
hydrogenase (GPDH) activity. Consequently, cells were 
not able to accumulate lipid droplets, suggesting that 
TGF β inhibits human adipose tissue development and 
reduces the activity of a lipogenic key enzyme in newly 
formed fat cells (24). 
Evaluating this literature, we have hypothesised that 
adipose tissue in OSMF could be reduced by over ex-
pression of TGF β. We demonstrated that TGF β expres-
sion in OSMF remains elevated as the disease progress-
es from Early to Advanced and there is a concomitant 
lack of adipose tissue in these cases. However, fibrosis 
in OSMF may still be derived from stromal cells and 
the decrease of fat cell could still be a consequence of 
inflammation. To definitively clarify a correlation be-
tween TGF β and fat content in OSMF, further studies 
with more samples are required. Adipose tissue is de-
rived from the embryonic mesenchyme and contains a 
stroma that is easily isolated. Few studies have recently 
recognized a stem cell population within the adipose 
stromal compartment, termed processed lipoaspirate 
cells, which can differentiate toward the adipogenic, 
chondrogenic myogenic and osteogenic lineages (25-
27). Preadipocytes are a feasible cell source for adipose 
tissue regeneration (28). Hence in future adipose tissue 
replacement could be used to treat OSMF cases. How-
ever, the enhancement of the in vivo adipogenic conver-
sion of preadipocytes remains a major challenge.
This study thus suggests TGF β to be the molecule par-
ticipating in lipodystrophy and inhibiting adipogenesis 
in OSMF. Loss of adipose tissue along with the fibrosis 
can be a cause of stiffness of oral mucosa and sunken 
appearance of cheeks in most OSMF cases. Further 
studies are required to investigate if replacement of adi-
pose tissue and augmentation of lost soft tissues in such 
patients could aid as a treatment modality in advanced 
OSMF.
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